Product
Lofexidine
Aliases
Lucemyra
Name
Lucemyra
INN Name
lofexidine hydrochloride
FDA Approved
Yes
6 clinical trials
1 organization
9 indications
1 document
Indication
Opioid-use DisorderIndication
Substance Use DisorderIndication
Opioid Use DisorderIndication
Opioid WithdrawalIndication
Opioid CravingIndication
AnxietyIndication
Opioid-Related DisordersIndication
Opioid DependenceIndication
Post-Traumatic Stress DisorderClinical trial
Impact of Lofexidine on Stress, Craving and Opioid UseStatus: Completed, Estimated PCD: 2024-01-30
Clinical trial
Evaluating a Mechanistically-Supported Pharmacotherapy to Treat Opioid WithdrawalStatus: Recruiting, Estimated PCD: 2027-01-31
Clinical trial
Evaluating a Neuromodulator Medical Device (Bridge Device) for Opioid Use Disorder TreatmentStatus: Recruiting, Estimated PCD: 2025-10-30
Clinical trial
Assessing a Clinically-meaningful Opioid Withdrawal PhenotypeStatus: Recruiting, Estimated PCD: 2025-11-30
Clinical trial
Combining Pregabalin (LYRICA®) With Lofexidine (LUCEMYRATM): Can it Increase the Success of Transition to Naltrexone?Status: Completed, Estimated PCD: 2023-03-23
Clinical trial
Lofexidine Combined With Buprenorphine for Reducing Symptoms of Post-Traumatic Stress Disorder (PTSD) and Opioid Use Relapse in VeteransStatus: Recruiting, Estimated PCD: 2024-11-30
Document
DailyMed Label: LucemyraOrganization
USWM, LLC